Cargando…
Recurrent coronary thrombotic events in a moderate case of COVID-19
We describe the case of a healthy patient with moderate COVID-19 infection without thrombophilia nor coronary disease background who presented with a relapsing thrombotic occlusion of the right coronary artery despite normal oxygenation, adequate antiaggregation and prophylactic anticoagulation. Pro...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843346/ https://www.ncbi.nlm.nih.gov/pubmed/33500300 http://dx.doi.org/10.1136/bcr-2020-237624 |
_version_ | 1783644121697615872 |
---|---|
author | Muguerza, Julian Loizeau, Pierre A |
author_facet | Muguerza, Julian Loizeau, Pierre A |
author_sort | Muguerza, Julian |
collection | PubMed |
description | We describe the case of a healthy patient with moderate COVID-19 infection without thrombophilia nor coronary disease background who presented with a relapsing thrombotic occlusion of the right coronary artery despite normal oxygenation, adequate antiaggregation and prophylactic anticoagulation. Prophylactic anticoagulation recommendations in COVID-19 were inadequate for this patient. Further data are needed to propose full-dose therapeutic anticoagulation for patients with coronary thrombosis and COVID-19 infection. This could nevertheless be considered even in mild forms of COVID-19. |
format | Online Article Text |
id | pubmed-7843346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-78433462021-01-29 Recurrent coronary thrombotic events in a moderate case of COVID-19 Muguerza, Julian Loizeau, Pierre A BMJ Case Rep Case Report We describe the case of a healthy patient with moderate COVID-19 infection without thrombophilia nor coronary disease background who presented with a relapsing thrombotic occlusion of the right coronary artery despite normal oxygenation, adequate antiaggregation and prophylactic anticoagulation. Prophylactic anticoagulation recommendations in COVID-19 were inadequate for this patient. Further data are needed to propose full-dose therapeutic anticoagulation for patients with coronary thrombosis and COVID-19 infection. This could nevertheless be considered even in mild forms of COVID-19. BMJ Publishing Group 2021-01-26 /pmc/articles/PMC7843346/ /pubmed/33500300 http://dx.doi.org/10.1136/bcr-2020-237624 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage |
spellingShingle | Case Report Muguerza, Julian Loizeau, Pierre A Recurrent coronary thrombotic events in a moderate case of COVID-19 |
title | Recurrent coronary thrombotic events in a moderate case of COVID-19 |
title_full | Recurrent coronary thrombotic events in a moderate case of COVID-19 |
title_fullStr | Recurrent coronary thrombotic events in a moderate case of COVID-19 |
title_full_unstemmed | Recurrent coronary thrombotic events in a moderate case of COVID-19 |
title_short | Recurrent coronary thrombotic events in a moderate case of COVID-19 |
title_sort | recurrent coronary thrombotic events in a moderate case of covid-19 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843346/ https://www.ncbi.nlm.nih.gov/pubmed/33500300 http://dx.doi.org/10.1136/bcr-2020-237624 |
work_keys_str_mv | AT muguerzajulian recurrentcoronarythromboticeventsinamoderatecaseofcovid19 AT loizeaupierrea recurrentcoronarythromboticeventsinamoderatecaseofcovid19 |